CLOV
BuyPremium GrowerFLAGClover Health Investments, Corp. · Healthcare · United States · $2.2B · Avg Vol: $19M/d
Premium Grower: Strong business with the market behind it, but you are paying up for it.
Insufficient evidence for a screen-pass. Clover Health Investments, Corp.: fails the quant gate on value (Q63/V35/M84; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT CLOVER HEALTH INVESTMENTS, CORP.
Read
Clover Health Investments, Corp. is a Medicare Advantage insurer that leverages its proprietary AI-powered technology platform, Clover Assistant, to proactively manage and improve health outcomes for its members. The company aims to differentiate itself by using data analytics to identify and address health risks, positioning itself as a technology-driven disruptor in the traditional healthcare plans market.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.1B | 1.3B | 1.4B | 1.9B | 20.6% | 2.5B | 3.0B | 3.5B | 35.4% |
| EPS | — | -0.71 | -0.44 | -0.08 | -0.17 | — | -0.05 | — | — | — |
| Shares | — | 478.4M | 489.1M | 503.5M | 519.0M | +8.5% | 435.4M | — | — | — |
| Debt | 27.8M | 5.9M | 4.7M | — | — | -59.1% | — | — | — | — |
| Equity | — | 356.9M | 286.4M | 341.1M | 308.7M | -4.7% | — | — | — | — |
| Op CF | — | -203.9M | -144.7M | 34.8M | -66.9M | — | 77.0M | — | — | — |
| Inv CF | — | 95.1M | 140.0M | 0.6M | 4.1M | — | — | — | — | — |
| Fin CF | — | -5.0M | -5.1M | -17.4M | -53.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CLOV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CLOV | Clover Health Investments, Corp.(you) | $2.2B | 79 | Buy |
| PGNY | Progyny, Inc. | $2.0B | 98 | Strong Buy |
| ALHC | Alignment Healthcare, Inc. | $2.8B | 59 | Hold |
| MOH | Molina Healthcare, Inc. | $10.4B | 71 | Buy |
| OSCR | Oscar Health, Inc. | $9.4B | 98 | Strong Buy |
| CNC | Centene Corporation | $32.0B | 93 | Strong Buy |
| HUM | Humana Inc. | $46.3B | 89 | Strong Buy |
| CI | The Cigna Group | $73.7B | 92 | Strong Buy |
| ELV | Elevance Health, Inc. | $85.5B | 90 | Strong Buy |
| CVS | CVS Health Corporation | $119.0B | 93 | Strong Buy |
Peer medians: ROE -31.0% · P/E 25.1x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.